Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forest Expects Multiple Celexa Generics To Enter Market In January

Executive Summary

Forest Labs is not putting any "impediments" in the way of generic applications for the antidepressant Celexa (citalopram), President Kenneth Goodman told the Friedman Billings Ramsey growth conference June 2 in New York
Advertisement

Related Content

Antidepressant Safety Concerns Depress Zoloft; Forest, Wyeth Still Happy
Antidepressant Safety Concerns Depress Zoloft; Forest, Wyeth Still Happy
Forest Takes On Merck, Novartis In Hypertension; Benicar Another Lexapro?
Forest Takes On Merck, Novartis In Hypertension; Benicar Another Lexapro?
Forest Expects Lexapro To Gain Market Share Despite Lilly Cymbalta Launch
Forest Expects Lexapro To Gain Market Share Despite Lilly Cymbalta Launch
Lexapro Switch Takes New Twist: Forest Launching Celexa Generic In 2005
Advertisement
UsernamePublicRestriction

Register

PS044113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel